Masakatsu Motomura

Safety and efficacy of eculizumab in anti-acetylcholine receptor antibody-positive refractory generalised myasthenia gravis (REGAIN): a phase 3, randomised, double-blind, placebo-controlled, multicentre study

James F. Howard, Kimiaki Utsugisawa, Michael Benatar et al. · The Lancet Neurology · 2017 · 800 citations

Medicine, Pharmacology, Pharmacotherapy +6

Autoantibodies to low‐density lipoprotein receptor–related protein 4 in myasthenia gravis

Osamu Higuchi, Johko Hamuro, Masakatsu Motomura et al. · Annals of Neurology · 2010 · 544 citations · Full text

Life Sciences, Immunology, Pathology +16

The Muscle Protein Dok-7 Is Essential for Neuromuscular Synaptogenesis

Kumiko Okada, Akane Inoue, Momoko Okada et al. · Science · 2006 · 430 citations

Life Sciences, Molecular Biology, Neuroscience +17

Dok-7 Mutations Underlie a Neuromuscular Junction Synaptopathy

David Beeson, Osamu Higuchi, Jackie Palace et al. · Science · 2006 · 269 citations

Medicine, Genetics, Neurology +17

An improved diagnostic assay for Lambert-Eaton myasthenic syndrome.

Masakatsu Motomura, I Johnston, Bethan Lang et al. · Journal of Neurology Neurosurgery & Psychiatry · 1995 · 258 citations · Full text

Medicine, Neurology, Neuroscience +17